What is the AbbVie Inc (ABBV) price today?

The price of AbbVie Inc (ABBV) today is $262.49. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/ABBV

Us company

AbbVie Inc (ABBV) Stock Price Today

Technicals Fundamentals Financials News Corp Action About Compare

24H

YTD

Aura AI Summary

AbbVie (ABBV) trades at $261.70, up 2.08% on the day, with a bullish technical outlook as it approaches resistance near $262. The company reported strong Q2 2026 EPS of $3.65, beating estimates, and maintains robust revenue growth driven by Skyrizi and Rinvoq. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing pipeline strength.

The stock offers a compelling growth story with a consensus price target of $281.41, though high P/E of 72.44 and looming patent cliffs in the 2030s present risks. Dividend growth is recovering, with a recent payout of $1.73, supporting income investors. Upside depends on execution against Humira declines and pipeline success.

Read full analysis

Key Stats

Market Cap
$459.43B
Volume
-
Sector
Health
52W High
$265.97
52W Low
$197.38
Typical Hold Time
-
Enterprise Value
$523.69B
Div Yield
2.7%
Trading Activity
-

$262.49

52W Low: $197.38

27 Apr 2026

52W High: $265.97

19 Aug 2026

Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $265.97, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Most Recent News

Content is generated by Aura AI

Ithaca Energy to join FTSE 100 on Sept 21, boosting investor exposure after key acquisitions.

Ithaca Energy PLC will be added to the FTSE 100 index on September 21, 2026, following FTSE Russell's latest review. This inclusion marks a significant milestone for the North Sea oil producer after expanding through acquisitions, including its merge...

Hutchmed shares jump 17% after $1.3B GSK deal for cancer drug rights outside China

Hutchmed's shares rose 17% after signing a licensing deal with GSK worth up to $1.295 billion for its experimental cancer drug HMPL-A830. GSK gains exclusive rights outside Mainland China, Hong Kong, Macau, and Taiwan, paying $110 million upfront plu...

AI ETFs CHAT and AGIX offer different risks and returns; CHAT leads but AGIX favored for US lab exposure.

KraneShares Public-Private AI & Technology ETF (CHAT) and Roundhill Generative AI & Technology ETF (AGIX) provide broad exposure to the AI ecosystem but differ in holdings and risk profiles. Since AGIX's inception, CHAT has outperformed by about 60%,...

Catch up fast with Aura AI

Get an AI-generated news summary for this asset in seconds.

Frequently Asked Questions

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

Are US Stocks safe?

Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

Market Cap
$459.43B
Volume
-
Sector
Health
52W High
$265.97
52W Low
$197.38
Typical Hold Time
-
Enterprise Value
$523.69B
Div Yield
2.7%
Trading Activity
-

$262.49

52W Low: $197.38

27 Apr 2026

52W High: $265.97

19 Aug 2026

Let’s invest in this asset by signing up or download!

AbbVie Inc (ABBV) Stock Price Today

Aura AI Summary

Key Stats

About AbbVie Inc

Most Recent News

Ithaca Energy to join FTSE 100 on Sept 21, boosting investor exposure after key acquisitions.

Hutchmed shares jump 17% after $1.3B GSK deal for cancer drug rights outside China

AI ETFs CHAT and AGIX offer different risks and returns; CHAT leads but AGIX favored for US lab exposure.

People also bought

Frequently Asked Questions

Key Stats

Invest

Features

Fees

Learn

Tools

Support

iOS App Store

Google Play Store